CERE — Cerevel Therapeutics Holdings Share News
0.000.00%
Last trade - 00:00Cerevel Therapeutics Holdings Inc reports results for the quarter ended in September - Earnings Summary
Brief: Cerevel Therapeutics Q3 Net Income USD -96.361 Million
Cerevel Therapeutics Holdings Inc expected to post a loss of 63 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius
Cerevel Therapeutics rallies after upsized $450 mln stock offering
Brief: Cerevel Therapeutics Announces Pricing Of $450 Mln Public Offering Of Common Stock
Brief: Cerevel Therapeutics Expects To Report That It Had About $758 Mln In Cash, Cash Equivalents And Marketable Securities As Of Sept 30, 2023
Brief: Cerevel Therapeutics Announces Proposed Public Offering Of Common Stock
U.S. RESEARCH ROUNDUP-Apellis Pharmaceuticals, CDW, Equinix
Cerevel Therapeutics Holdings Inc reports results for the quarter ended in June - Earnings Summary
Cerevel Therapeutics Holdings Inc expected to post a loss of 65 cents a share - Earnings Preview
Brief: Cerevel Therapeutics Appoints Paul Burgess As Chief Business Development Officer
U.S. STOCKS ON THE MOVE-First Citizens BancShares, Sarepta, Celsius Holdings
U.S. STOCKS ON THE MOVE-Taboola, US banks, Copper miners
Cerevel Therapeutics rises on new CFO appointment
Brief: Cerevel Therapeutics Appoints Susan Altschuller, Ph.D. As CFO
U.S. STOCKS ON THE MOVE-Ruth's Hospitality, Mirion Technologies, Qualcomm
Cerevel Therapeutics Holdings Inc reports results for the quarter ended in March - Earnings Summary
Cerevel Therapeutics drops on wider Q1 loss